|
2014-05-16 |
2014-05-16 |
V
Verkauf
|
OCAMPO CHRISTINE
Vice President, Finance
Führungsperson
|
11.900
-79.9%
4,88
58.072 USD
|
11.900
-79.9%
|
4,88
|
58.072 USD
|
|
|
2013-12-19 |
2013-12-17 |
K
Kauf
|
PALEKAR ROHAN
SVP & Chief Commercial Officer
Führungsperson
|
10.000
+7.5%
2,80
28.000 USD
|
10.000
+7.5%
|
2,80
|
28.000 USD
|
|
|
2013-11-05 |
2013-11-04 |
K
Kauf
|
PALEKAR ROHAN
SVP & Chief Commercial Officer
Führungsperson
|
10.000
+8.1%
4,19
41.895 USD
|
10.000
+8.1%
|
4,19
|
41.895 USD
|
|
|
2012-05-14 |
2012-05-10 |
K
Kauf
|
Siffert Joao MD
SVP, R&D
Führungsperson
|
2.700
+9.2%
2,96
7.992 USD
|
2.700
+9.2%
|
2,96
|
7.992 USD
|
|
|
2012-03-07 |
2012-03-06 |
K
Kauf
|
MATHEWS CHARLES
Nicht geschäftsführender Verwaltungsratsmitglied
|
5.000
+inf%
2,69
13.473 USD
|
5.000
+inf%
|
2,69
|
13.473 USD
|
|
|
2012-03-07 |
2012-03-06 |
K
Kauf
|
OCAMPO CHRISTINE
Vice President, Finance
Führungsperson
|
3.000
+inf%
2,60
7.795 USD
|
3.000
+inf%
|
2,60
|
7.795 USD
|
|
|
2010-11-10 |
2010-11-09 |
V
Verkauf
|
Clarus Lifesciences I, L.P.
Large shareholder
|
1.200.000
-15.2%
4,81
5.773.920 USD
|
1.200.000
-15.2%
|
4,81
|
5.773.920 USD
|
|
|
2010-11-10 |
2010-11-08 |
V
Verkauf
|
Clarus Lifesciences I, L.P.
Large shareholder
|
44.626
-0.6%
5,10
227.593 USD
|
44.626
-0.6%
|
5,10
|
227.593 USD
|
|
|
2010-11-05 |
2010-11-05 |
V
Verkauf
|
Clarus Lifesciences I, L.P.
Large shareholder
|
332.572
-4.0%
4,80
1.597.377 USD
|
332.572
-4.0%
|
4,80
|
1.597.377 USD
|
|
|
2010-11-05 |
2010-11-03 |
V
Verkauf
|
Clarus Lifesciences I, L.P.
Large shareholder
|
1.400.106
-14.5%
4,52
6.332.539 USD
|
1.400.106
-14.5%
|
4,52
|
6.332.539 USD
|
|
|
2010-11-02 |
2010-11-02 |
V
Verkauf
|
Clarus Lifesciences I, L.P.
Large shareholder
|
1.290.871
-11.8%
4,49
5.800.400 USD
|
1.290.871
-11.8%
|
4,49
|
5.800.400 USD
|
|
|
2010-11-02 |
2010-11-01 |
V
Verkauf
|
Clarus Lifesciences I, L.P.
Large shareholder
|
2.478.142
-18.5%
5,36
13.273.424 USD
|
2.478.142
-18.5%
|
5,36
|
13.273.424 USD
|
|
|
2010-11-02 |
2010-10-29 |
V
Verkauf
|
Clarus Lifesciences I, L.P.
Large shareholder
|
1.424.947
-9.6%
5,06
7.215.647 USD
|
1.424.947
-9.6%
|
5,06
|
7.215.647 USD
|
|
|
2010-10-12 |
2010-10-11 |
V
Verkauf
|
Clarus Lifesciences I, L.P.
Large shareholder
|
311.000
-2.1%
3,52
1.093.445 USD
|
311.000
-2.1%
|
3,52
|
1.093.445 USD
|
|
|
2010-10-12 |
2010-10-08 |
V
Verkauf
|
Clarus Lifesciences I, L.P.
Large shareholder
|
240.838
-1.6%
3,47
836.792 USD
|
240.838
-1.6%
|
3,47
|
836.792 USD
|
|
|
2010-07-15 |
2010-07-13 |
V
Verkauf
|
Clarus Lifesciences I, L.P.
Large shareholder
|
165.000
-1.1%
3,53
583.143 USD
|
165.000
-1.1%
|
3,53
|
583.143 USD
|
|
|
2009-10-13 |
2009-10-13 |
V
Verkauf
|
Moorin Jay
Large shareholder
|
547.135
-7.1%
2,23
1.220.111 USD
|
547.135
-7.1%
|
2,23
|
1.220.111 USD
|
|
|
2009-10-13 |
2009-10-12 |
V
Verkauf
|
Moorin Jay
Large shareholder
|
427.145
-5.3%
2,12
905.547 USD
|
427.145
-5.3%
|
2,12
|
905.547 USD
|
|
|
2009-10-13 |
2009-10-09 |
V
Verkauf
|
Moorin Jay
Large shareholder
|
804.712
-9.0%
2,46
1.979.592 USD
|
804.712
-9.0%
|
2,46
|
1.979.592 USD
|
|
|
2009-08-13 |
2009-08-11 |
V
Verkauf
|
Vivo Ventures Fund VI, L.P.
Large shareholder
|
232.450
-2.8%
3,37
783.938 USD
|
232.450
-2.8%
|
3,37
|
783.938 USD
|
|
|
2009-08-13 |
2009-08-11 |
V
Verkauf
|
Moorin Jay
Large shareholder
|
894.120
-9.1%
3,58
3.200.950 USD
|
894.120
-9.1%
|
3,58
|
3.200.950 USD
|
|
|
2009-08-13 |
2009-08-11 |
V
Verkauf
|
Vivo Ventures Fund VI, L.P.
Large shareholder
|
49.800
-0.6%
4,05
201.690 USD
|
49.800
-0.6%
|
4,05
|
201.690 USD
|
|
|
2009-08-03 |
2009-07-31 |
V
Verkauf
|
Vivo Ventures Fund VI, L.P.
Large shareholder
|
1.400
-0.0%
2,20
3.080 USD
|
1.400
-0.0%
|
2,20
|
3.080 USD
|
|
|
2009-08-03 |
2009-07-30 |
V
Verkauf
|
Vivo Ventures Fund VI, L.P.
Large shareholder
|
142.366
-1.7%
2,29
326.445 USD
|
142.366
-1.7%
|
2,29
|
326.445 USD
|
|
|
2009-08-03 |
2009-07-29 |
V
Verkauf
|
Vivo Ventures Fund VI, L.P.
Large shareholder
|
145.500
-1.7%
2,28
331.245 USD
|
145.500
-1.7%
|
2,28
|
331.245 USD
|
|
|
2009-08-03 |
2009-07-28 |
V
Verkauf
|
Vivo Ventures Fund VI, L.P.
Large shareholder
|
122.100
-1.4%
2,42
295.714 USD
|
122.100
-1.4%
|
2,42
|
295.714 USD
|
|
|
2008-10-24 |
2008-10-22 |
K
Kauf
|
Moorin Jay
Large shareholder
|
10.600
+0.1%
0,48
5.088 USD
|
10.600
+0.1%
|
0,48
|
5.088 USD
|
|
|
2008-10-15 |
2008-10-15 |
K
Kauf
|
Moorin Jay
Large shareholder
|
6.465
+0.1%
0,49
3.168 USD
|
6.465
+0.1%
|
0,49
|
3.168 USD
|
|
|
2008-10-15 |
2008-10-14 |
K
Kauf
|
Moorin Jay
Large shareholder
|
32.300
+0.3%
0,50
16.150 USD
|
32.300
+0.3%
|
0,50
|
16.150 USD
|
|
|
2008-10-15 |
2008-10-10 |
K
Kauf
|
Moorin Jay
Large shareholder
|
73.551
+0.8%
0,45
33.098 USD
|
73.551
+0.8%
|
0,45
|
33.098 USD
|
|
|
2008-10-10 |
2008-10-09 |
K
Kauf
|
Moorin Jay
Large shareholder
|
41.385
+0.4%
0,48
19.865 USD
|
41.385
+0.4%
|
0,48
|
19.865 USD
|
|
|
2008-10-10 |
2008-10-08 |
K
Kauf
|
Moorin Jay
Large shareholder
|
114.384
+1.2%
0,50
57.192 USD
|
114.384
+1.2%
|
0,50
|
57.192 USD
|
|
|
2008-10-10 |
2008-10-07 |
K
Kauf
|
Moorin Jay
Large shareholder
|
21.318
+0.2%
0,48
10.233 USD
|
21.318
+0.2%
|
0,48
|
10.233 USD
|
|
|
2008-09-17 |
2008-09-17 |
K
Kauf
|
Moorin Jay
Large shareholder
|
413.217
+4.5%
0,80
330.574 USD
|
413.217
+4.5%
|
0,80
|
330.574 USD
|
|
|
2008-09-17 |
2008-09-16 |
K
Kauf
|
Moorin Jay
Large shareholder
|
17.387
+0.2%
0,76
13.214 USD
|
17.387
+0.2%
|
0,76
|
13.214 USD
|
|
|
2008-09-17 |
2008-09-15 |
K
Kauf
|
Moorin Jay
Large shareholder
|
244.449
+2.8%
0,85
207.782 USD
|
244.449
+2.8%
|
0,85
|
207.782 USD
|
|
|
2008-09-10 |
2008-09-10 |
K
Kauf
|
Moorin Jay
Large shareholder
|
48.103
+0.5%
0,91
43.774 USD
|
48.103
+0.5%
|
0,91
|
43.774 USD
|
|
|
2008-09-10 |
2008-09-09 |
K
Kauf
|
Moorin Jay
Large shareholder
|
146.400
+1.7%
0,92
134.688 USD
|
146.400
+1.7%
|
0,92
|
134.688 USD
|
|
|
2008-09-10 |
2008-09-08 |
K
Kauf
|
Moorin Jay
Large shareholder
|
125.000
+1.5%
0,95
118.750 USD
|
125.000
+1.5%
|
0,95
|
118.750 USD
|
|
|
2008-09-04 |
2008-09-04 |
K
Kauf
|
Moorin Jay
Large shareholder
|
52.113
+0.6%
0,95
49.507 USD
|
52.113
+0.6%
|
0,95
|
49.507 USD
|
|
|
2008-09-04 |
2008-09-03 |
K
Kauf
|
Moorin Jay
Large shareholder
|
6.864
+0.1%
0,93
6.384 USD
|
6.864
+0.1%
|
0,93
|
6.384 USD
|
|
|
2008-09-04 |
2008-09-02 |
K
Kauf
|
Moorin Jay
Large shareholder
|
323.550
+4.0%
0,93
300.902 USD
|
323.550
+4.0%
|
0,93
|
300.902 USD
|
|
|
2008-08-29 |
2008-08-27 |
K
Kauf
|
Moorin Jay
Large shareholder
|
89.447
+1.1%
0,95
84.975 USD
|
89.447
+1.1%
|
0,95
|
84.975 USD
|
|
|
2008-08-18 |
2008-08-15 |
K
Kauf
|
Moorin Jay
Large shareholder
|
114.032
+1.4%
0,95
108.330 USD
|
114.032
+1.4%
|
0,95
|
108.330 USD
|
|
|
2008-08-18 |
2008-08-14 |
K
Kauf
|
Moorin Jay
Large shareholder
|
6.051
+0.1%
0,90
5.446 USD
|
6.051
+0.1%
|
0,90
|
5.446 USD
|
|
|
2008-08-08 |
2008-08-07 |
K
Kauf
|
Moorin Jay
Large shareholder
|
91.380
+1.2%
0,98
89.552 USD
|
91.380
+1.2%
|
0,98
|
89.552 USD
|
|
|
2008-08-08 |
2008-08-06 |
K
Kauf
|
Moorin Jay
Large shareholder
|
400
+0.0%
0,90
360 USD
|
400
+0.0%
|
0,90
|
360 USD
|
|
|
2006-06-07 |
2006-05-31 |
V
Verkauf
|
SILVERSTEIN JONATHAN
Nicht geschäftsführender Verwaltungsratsmitglied
|
629.121
-26.9%
9,79
6.159.095 USD
|
629.121
-26.9%
|
9,79
|
6.159.095 USD
|
|
|
2006-06-02 |
2006-05-31 |
K
Kauf
|
Podlesak Dennis
Nicht geschäftsführender Verwaltungsratsmitglied
|
200
+2.8%
9,91
1.982 USD
|
200
+2.8%
|
9,91
|
1.982 USD
|
|
|
2006-06-02 |
2006-05-31 |
V
Verkauf
|
ORBIMED ADVISORS LLC
Nicht geschäftsführender Verwaltungsratsmitglied
|
629.121
-26.9%
9,79
6.159.095 USD
|
629.121
-26.9%
|
9,79
|
6.159.095 USD
|
|
|
2006-06-02 |
2006-05-31 |
K
Kauf
|
Podlesak Dennis
Nicht geschäftsführender Verwaltungsratsmitglied
|
800
+12.4%
9,90
7.920 USD
|
800
+12.4%
|
9,90
|
7.920 USD
|
|
|
2006-05-26 |
2006-05-26 |
K
Kauf
|
Kaye Randall
VP of Medical Affairs
Führungsperson
|
250
+inf%
9,90
2.475 USD
|
250
+inf%
|
9,90
|
2.475 USD
|
|
|
2006-05-26 |
2006-05-26 |
K
Kauf
|
Kaye Randall
VP of Medical Affairs
Führungsperson
|
200
+400.0%
9,90
1.980 USD
|
200
+400.0%
|
9,90
|
1.980 USD
|
|
|
2006-05-26 |
2006-05-26 |
K
Kauf
|
Kaye Randall
VP of Medical Affairs
Führungsperson
|
50
+inf%
9,89
495 USD
|
50
+inf%
|
9,89
|
495 USD
|
|
|
2006-05-26 |
2006-05-26 |
K
Kauf
|
HANSON GREGORY P
Vice President, CAO
Führungsperson
|
100
+2.0%
9,68
968 USD
|
100
+2.0%
|
9,68
|
968 USD
|
|
|
2006-05-26 |
2006-05-26 |
K
Kauf
|
HANSON GREGORY P
Vice President, CAO
Führungsperson
|
100
+2.0%
9,67
967 USD
|
100
+2.0%
|
9,67
|
967 USD
|
|
|
2006-05-26 |
2006-05-26 |
K
Kauf
|
HANSON GREGORY P
Vice President, CAO
Führungsperson
|
300
+6.4%
9,69
2.907 USD
|
300
+6.4%
|
9,69
|
2.907 USD
|
|
|
2006-05-26 |
2006-05-26 |
K
Kauf
|
Kaye Randall
VP of Medical Affairs
Führungsperson
|
2.000
+inf%
10,14
20.280 USD
|
2.000
+inf%
|
10,14
|
20.280 USD
|
|
|
2006-05-26 |
2006-05-26 |
K
Kauf
|
HANSON GREGORY P
Vice President, CAO
Führungsperson
|
600
+14.8%
9,65
5.790 USD
|
600
+14.8%
|
9,65
|
5.790 USD
|
|
|
2006-05-25 |
2006-05-25 |
K
Kauf
|
BRANDT ERIC
President, CEO & Director
Geschäftsführender Verwaltungsratsmitglied
|
89
+0.0%
8,96
797 USD
|
89
+0.0%
|
8,96
|
797 USD
|
|
|
2006-05-25 |
2006-05-25 |
K
Kauf
|
BRANDT ERIC
President, CEO & Director
Geschäftsführender Verwaltungsratsmitglied
|
2.911
+1.1%
8,97
26.112 USD
|
2.911
+1.1%
|
8,97
|
26.112 USD
|
|
|
2006-05-25 |
2006-05-25 |
K
Kauf
|
BRANDT ERIC
President, CEO & Director
Geschäftsführender Verwaltungsratsmitglied
|
1.700
+0.7%
8,99
15.283 USD
|
1.700
+0.7%
|
8,99
|
15.283 USD
|
|
|
2006-05-25 |
2006-05-25 |
K
Kauf
|
PUNTORIERO MICHAEL J
Senior VP, Finance, CFO
Führungsperson
|
2.500
+44.4%
9,00
22.500 USD
|
2.500
+44.4%
|
9,00
|
22.500 USD
|
|
|
2006-05-25 |
2006-05-25 |
K
Kauf
|
Katkin Keith
Sr. V.P. of Sales & Marketing
Führungsperson
|
1.700
+212.5%
9,00
15.300 USD
|
1.700
+212.5%
|
9,00
|
15.300 USD
|
|
|
2006-05-25 |
2006-05-25 |
K
Kauf
|
BRANDT ERIC
President, CEO & Director
Geschäftsführender Verwaltungsratsmitglied
|
6.300
+2.5%
9,00
56.700 USD
|
6.300
+2.5%
|
9,00
|
56.700 USD
|
|
|
2006-05-25 |
2006-05-25 |
K
Kauf
|
EMANUELE ROBERT MARTIN
V P, Business Development
Führungsperson
|
1.000
+inf%
8,99
8.990 USD
|
1.000
+inf%
|
8,99
|
8.990 USD
|
|
|
2006-05-25 |
2006-05-25 |
K
Kauf
|
PUNTORIERO MICHAEL J
Senior VP, Finance, CFO
Führungsperson
|
5.000
+800.0%
9,05
45.250 USD
|
5.000
+800.0%
|
9,05
|
45.250 USD
|
|
|
2006-05-25 |
2006-05-25 |
K
Kauf
|
Katkin Keith
Sr. V.P. of Sales & Marketing
Führungsperson
|
800
+inf%
8,98
7.184 USD
|
800
+inf%
|
8,98
|
7.184 USD
|
|
|
2006-02-22 |
2006-02-17 |
V
Verkauf
|
SIRCAR JAGADISH C
VP of Drug Discovery
Führungsperson
|
3.600
-22.2%
16,82
60.552 USD
|
3.600
-22.2%
|
16,82
|
60.552 USD
|
|
|
2006-02-15 |
2006-02-14 |
K
Kauf
|
Mazzo David J
Nicht geschäftsführender Verwaltungsratsmitglied
|
1.000
+15.5%
15,59
15.590 USD
|
1.000
+15.5%
|
15,59
|
15.590 USD
|
|
|
2005-10-24 |
2005-10-20 |
K
Kauf
|
SILVERSTEIN JONATHAN
Nicht geschäftsführender Verwaltungsratsmitglied
|
566.038
+6.5%
2,65
1.500.001 USD
|
566.038
+6.5%
|
2,65
|
1.500.001 USD
|
|
|
2005-04-12 |
2005-04-08 |
K
Kauf
|
SILVERSTEIN JONATHAN
Nicht geschäftsführender Verwaltungsratsmitglied
|
900.000
+11.4%
2,20
1.980.000 USD
|
900.000
+11.4%
|
2,20
|
1.980.000 USD
|
|
|
2005-01-03 |
2005-01-03 |
GV
Geplanter Verkauf
|
HANSEN JOHN DAVID
V.P. of Corporate Development
Führungsperson
|
10.200
-40.5%
3,40
34.680 USD
|
10.200
-40.5%
|
3,40
|
34.680 USD
|
|
|
2005-01-03 |
2005-01-03 |
GV
Geplanter Verkauf
|
HANSEN JOHN DAVID
V.P. of Corporate Development
Führungsperson
|
4.800
-16.0%
3,39
16.254 USD
|
4.800
-16.0%
|
3,39
|
16.254 USD
|
|
|
2005-01-03 |
2005-01-03 |
GV
Geplanter Verkauf
|
HANSEN JOHN DAVID
V.P. of Corporate Development
Führungsperson
|
600
-3.8%
3,42
2.052 USD
|
600
-3.8%
|
3,42
|
2.052 USD
|
|
